Guggenheim Capital’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$356K Sell
27,783
-569
-2% -$7.29K ﹤0.01% 1338
2025
Q1
$360K Buy
28,352
+12,299
+77% +$156K ﹤0.01% 1347
2024
Q4
$211K Buy
+16,053
New +$211K ﹤0.01% 1582
2024
Q3
Sell
-27,505
Closed -$390K 1897
2024
Q2
$390K Buy
27,505
+1,882
+7% +$26.7K ﹤0.01% 1541
2024
Q1
$349K Sell
25,623
-3,564
-12% -$48.6K ﹤0.01% 1610
2023
Q4
$393K Buy
29,187
+1,079
+4% +$14.5K ﹤0.01% 1551
2023
Q3
$351K Buy
28,108
+112
+0.4% +$1.4K ﹤0.01% 1570
2023
Q2
$379K Buy
27,996
+3,021
+12% +$40.9K ﹤0.01% 1572
2023
Q1
$348K Buy
24,975
+14,241
+133% +$198K ﹤0.01% 1630
2022
Q4
$153K Buy
+10,734
New +$153K ﹤0.01% 1837
2022
Q1
Sell
-10,792
Closed -$208K 2149
2021
Q4
$208K Sell
10,792
-11,759
-52% -$227K ﹤0.01% 2024
2021
Q3
$469K Buy
22,551
+44
+0.2% +$915 ﹤0.01% 1761
2021
Q2
$483K Sell
22,507
-1,760
-7% -$37.8K ﹤0.01% 1843
2021
Q1
$479K Sell
24,267
-1,078
-4% -$21.3K ﹤0.01% 1730
2020
Q4
$500K Sell
25,345
-115
-0.5% -$2.27K ﹤0.01% 1639
2020
Q3
$447K Buy
25,460
+3,433
+16% +$60.3K ﹤0.01% 1483
2020
Q2
$396K Sell
22,027
-8,682
-28% -$156K ﹤0.01% 1516
2020
Q1
$460K Buy
30,709
+6,654
+28% +$99.7K ﹤0.01% 1387
2019
Q4
$419K Buy
24,055
+7,370
+44% +$128K ﹤0.01% 1659
2019
Q3
$252K Sell
16,685
-1,114
-6% -$16.8K ﹤0.01% 1924
2019
Q2
$300K Sell
17,799
-87
-0.5% -$1.47K ﹤0.01% 1864
2019
Q1
$306K Sell
17,886
-514
-3% -$8.79K ﹤0.01% 1890
2018
Q4
$278K Buy
18,400
+4,155
+29% +$62.8K ﹤0.01% 1924
2018
Q3
$291K Buy
+14,245
New +$291K ﹤0.01% 2218
2016
Q2
Sell
-20,664
Closed -$371K 2899
2016
Q1
$371K Sell
20,664
-2,306
-10% -$41.4K ﹤0.01% 2481
2015
Q4
$543K Sell
22,970
-4,565
-17% -$108K ﹤0.01% 2412
2015
Q3
$620K Sell
27,535
-4,298
-14% -$96.8K ﹤0.01% 2331
2015
Q2
$898K Sell
31,833
-1,303
-4% -$36.8K ﹤0.01% 2273
2015
Q1
$913K Sell
33,136
-806
-2% -$22.2K ﹤0.01% 2281
2014
Q4
$844K Buy
33,942
+7,391
+28% +$184K ﹤0.01% 2302
2014
Q3
$587K Buy
+26,551
New +$587K ﹤0.01% 2457